| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 3.2, positive 3.7, negative -0.5) on 20251002. The forces of Price Level (2), Sentiment towards Fundamentals (2), Option Speculation (1.5), Sector Price Trend (1.2), Broad Market Trend (0.6), and Valuation Sentiment (-1) will drive up the price. The forces of and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.7). The extreme bullish overall sentiment (3.2) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-02 | 2% | 1.3% | 143.16 | 111 | -0.16% | 0.44% | 1.8 | 1.2 | 2 | 2.7 |
| 2025-10-01 | 2% | 1.3% | 143.39 | 132 | 3.01% | 0.44% | 0.6 | 1 | 1.5 | 6.6 |
| 2025-09-30 | 2% | 1.1% | 139.2 | 92 | 2.43% | 0.22% | 1.2 | 0.3 | 1.5 | 5.6 |
| 2025-09-29 | 1% | 1% | 135.9 | 23 | 0.28% | -0.07% | 0.8 | -0.2 | 1.2 | 1.3 |
| 2025-09-28 | 1% | 1.4% | 0.3 | -0.3 | 0.6 | 7 | ||||
| 2025-09-27 | 0% | 1.9% | 0.2 | -0.3 | 0.5 | 0 | ||||
| 2025-09-26 | 1% | 2% | 135.52 | 11 | 1.01% | -0.22% | -0.1 | -0.3 | -0.1 | 2 |
| 2025-09-25 | 2% | 1.9% | 134.16 | -26 | -1.65% | -0.44% | 0.4 | -0.4 | 0.1 | -0.3 |
| 2025-09-24 | 1% | 1.6% | 136.41 | 17 | -0.39% | -0.07% | 0.6 | -0.2 | 0.5 | 2 |
| 2025-09-23 | 1% | 1.4% | 136.95 | 34 | 0.25% | -0.07% | 0.5 | -0.1 | 0.6 | 2.6 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (-4) Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors Shares of Bristol Myers Squibb Co. BMY shed 3.58% to $45.73 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,715.35 and the Dow Jones Industrial Average DJIA rising 0.17% to 46,519.72. The stock's fall snapped a four-day winning streak. (https://www.marketwatch.com/) Thu. Oct 2, 2025 | |
| 2 (7) Humana Affirms Outlook, Calls Star Ratings In-Line With View Humana Inc. shares jumped after the company affirmed its earnings guidance for 2025, reassuring investors who have been blindsided by insurance companies’ outlook cuts this year. (https://www.bloomberg.com/) Thu. Oct 2, 2025 | |
| 3 (5) A health-care stock that's maintaining momentum despite regulatory headwinds Frank Holland breaks down what traders are watching ahead of the new session. (https://www.cnbc.com/) Thu. Oct 2, 2025 | |
| 4 (8) This Best Stock is the Salesforce of drug discovery. Time to get long here Josh and Sean break down the reason behind the momentum of this unique healthcare stock. (https://www.cnbc.com/) Thu. Oct 2, 2025 | |
| 5 (-7) Medicare changes could delay or deny healthcare, demand prior approvals for treatment Accountable care organizations — which run like Medicare Advantage plans — get financially penalized when they spend too much. This may be where Medicare is heading. (https://www.marketwatch.com/) Thu. Oct 2, 2025 | |
| 6 (7) 6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal Market Analysis by covering: Eli Lilly and Company, Merck & Company Inc, Biogen Inc, Pfizer Inc. Read 's Market Analysis on Investing.com (https://www.investing.com/) Thu. Oct 2, 2025 | |
| 7 (7) Eli Lilly Shares Are Trading Higher Wednesday: What's Going On? Eli Lilly shares are trading higher Wednesday after Trump recently announced a deal with Pfizer as well as the 'TrumpRx' site to decrease prices. (https://www.benzinga.com/) Wed. Oct 1, 2025 | |
| 8 (3) Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday? Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. (https://www.benzinga.com/) Wed. Oct 1, 2025 | |
| 9 (8) Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs. (https://www.benzinga.com/) Wed. Oct 1, 2025 | |
| 10 (5) S&P 500 Gains and Losses Today: AES and Pharma Stocks Soar; Corteva Drops Shares of a power generator surged on Wednesday, Oct. 1, 2025, after reports of a possible takeover, while a separation plan weighed on a seed and crop protection company. (https://finance.yahoo.com/) Wed. Oct 1, 2025 | |
| 11 (8) Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market Shares of Thermo Fisher Scientific Inc. TMO rose 9.42% to $530.73 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.34% to 6,711.20 and the Dow Jones Industrial Average DJIA rising 0.09% to 46,441.10. This was the stock's second consecutive day of gains. (https://www.marketwatch.com/) Wed. Oct 1, 2025 | |
| 12 (8) Charles River Laboratories International Inc. stock outperforms competitors on strong trading day Shares of Charles River Laboratories International Inc. CRL advanced 8.96% to $170.48 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.34% to 6,711.20 and the Dow Jones Industrial Average DJIA rising 0.09% to 46,441.10. This was the stock's second consecutive day of gains. (https://www.marketwatch.com/) Wed. Oct 1, 2025 | |
| 13 (8) Bio-Techne Corp. stock outperforms competitors on strong trading day Shares of Bio-Techne Corp. TECH rallied 7.71% to $59.92 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.34% to 6,711.20 and the Dow Jones Industrial Average DJIA rising 0.09% to 46,441.10. This was the stock's fourth consecutive day of gains. (https://www.marketwatch.com/) Wed. Oct 1, 2025 | |
| 14 (3) Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away Pfizer's deal with TrumpRx for steep drug discounts could impact UnitedHealth, Eli Lilly, and CVS. Here's how... (https://www.benzinga.com/) Wed. Oct 1, 2025 | |
| 15 (8) Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know Pfizer's CEO says the deal with the Trump administration is "a win" for the company. He's probably right. (https://www.fool.com/) Wed. Oct 1, 2025 | |
| 16 (8) EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare institutions and plans to expand further. (https://www.benzinga.com/) Wed. Oct 1, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA